Literature DB >> 17719223

Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.

Chenzhong Liao1, Rajeshri G Karki, Christophe Marchand, Yves Pommier, Marc C Nicklaus.   

Abstract

To address the absence of experimental data on the full-length structure of HIV-1 integrase and the way it binds to viral and human DNA, we had previously [Karki, R. G.; Tang, Y.; Burke, T. R., Jr.; Nicklaus, M. C. J. Comput. Aided Mol. Des.2004, 18, 739] constructed models of full-length HIV-1 integrase complexed with models of viral and human DNA. Here we describe the discovery of novel HIV-1 integrase strand transfer inhibitors based on one of these models. Virtual screening methods including docking and filtering by predicted ADME/Tox properties yielded several microM level inhibitors of the strand transfer reaction catalyzed by wild-type HIV-1 integrase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719223     DOI: 10.1016/j.bmcl.2007.08.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Tautomerism and magnesium chelation of HIV-1 integrase inhibitors: a theoretical study.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  ChemMedChem       Date:  2010-07-05       Impact factor: 3.466

Review 2.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

Review 3.  Advances in computationally modeling human oral bioavailability.

Authors:  Junmei Wang; Tingjun Hou
Journal:  Adv Drug Deliv Rev       Date:  2015-01-09       Impact factor: 15.470

Review 4.  Software and resources for computational medicinal chemistry.

Authors:  Chenzhong Liao; Markus Sitzmann; Angelo Pugliese; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2011-06       Impact factor: 3.808

5.  Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.

Authors:  Barry C Johnson; Mathieu Métifiot; Yves Pommier; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

6.  Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.

Authors:  Mark G Lewis; Sandro Norelli; Matt Collins; Maria Letizia Barreca; Nunzio Iraci; Barbara Chirullo; Jake Yalley-Ogunro; Jack Greenhouse; Fausto Titti; Enrico Garaci; Andrea Savarino
Journal:  Retrovirology       Date:  2010-03-16       Impact factor: 4.602

7.  Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor.

Authors:  Fabrice Michel; Corinne Crucifix; Florence Granger; Sylvia Eiler; Jean-François Mouscadet; Sergei Korolev; Julia Agapkina; Rustam Ziganshin; Marina Gottikh; Alexis Nazabal; Stéphane Emiliani; Richard Benarous; Dino Moras; Patrick Schultz; Marc Ruff
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

Review 8.  Understanding infectious agents from an in silico perspective.

Authors:  Joo Chuan Tong; Lisa F P Ng
Journal:  Drug Discov Today       Date:  2010-10-23       Impact factor: 7.851

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.